Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis
多发性硬化症一线疾病修饰治疗中,启动高效疗法与平台疗法的预测因素
期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2026.1738815
Bin Aziz, Khalid; Alhowaish, Thamer S; Alanazi, Feras; Alghanim, Mezyed; Alkhreigi, Saleh; Almubarak, Fahad; Aleisa, Faisal; AlTuwaijri, Nouf; Alanazi, Raghad; Al Malik, Yaser